Abstract
INTRODUCTION: Chest Compression Synchronized Ventilation (CCSV) is a novel approach aimed at optimizing gas exchange and hemodynamics during cardiopulmonary resuscitation (CPR). However, its clinical value, safety profile and implementation barriers remain unclear. This study aimed to systematically synthesize existing evidence on the use of CCSV during cardiac arrest in animals and humans. METHODS: We conducted a scoping review and systematically searched five databases (Medline, Embase, CENTRAL, Scopus, Web of Science) up to May 2025. Studies investigating CCSV or mechanistically related ventilation strategies during cardiac arrest were included regardless of study design, language or publication date. Data were charted for study characteristics, outcomes and adverse events. RESULTS: Thirty-two studies published between 1980 and 2025 were included. Most were animal studies (n=19), primarily conducted in pigs, with limited human data (n=10). CCSV showed positive effects on arterial oxygenation, carbon dioxide clearance, and hemodynamic parameters as well as cerebral oxygenation compared to conventional ventilation modes. Adverse events such as pneumothorax and lung injury were inconsistently reported. CONCLUSIONS: Available data on CCSV suggests potential physiological benefits during CPR, particularly in experimental settings. Human data remain scarce, and larger, prospective human trials are essential to evaluate clinical effectiveness, guide implementation, and assess risks compared to conventional ventilation strategies.